David L. Nathan Joins Cannabis Science and Technology’s Editorial Advisory Board
Cannabis Science and Technology is pleased to announce the addition of David L. Nathan MD, DFAPA to its editorial advisory board (EAB).
Cannabis Science and Technology is pleased to announce the addition of David L. Nathan MD, DFAPA to its editorial advisory board (EAB).
Located in Princeton, New Jersey, Dr. Nathan is a psychiatrist, writer, speaker, educator, and consultant. Among his many talents, Dr. Nathan founded Doctors for Cannabis Regulation (DFCR), where he also holds the title of board president. He is also a founding steering committee member of New Jersey United for Marijuana Reform. In 2019, Dr. Nathan was one of two physicians to testify at the first United States House Judiciary Committee hearing regarding cannabis legislation.
Dr. Nathan graduated magna cum laude from Princeton University and he received his MD from the University of Pennsylvania School of Medicine. He then went on to complete his psychiatry residency at McLean Hospital of Harvard Medical School. Dr. Nathan is a Distinguished Fellow of the American Psychiatric Association, Clinical Associate Professor of Psychiatry at Rutgers Robert Wood Johnson Medical School, and a community fellow at Mathey College of Princeton University.
Dr. Nathan has written and spoken extensively on cannabis policy, with audiences ranging from lawmakers, businesspeople, state medical societies, hospital medical staff, allied health professionals, and the lay public. He has testified before eight state legislatures and the U.S. Congress, and he coauthored a landmark article on cannabis regulation with former Surgeon General Joycelyn Elders for the American Journal of Public Health.
Dr. Nathan has appeared in nationally syndicated broadcast, online and print media publications, with more prominent outlets including CNN, The New York Times, Wall Street Journal, Washington Post, US News & World Report, VICE News, San Francisco Chronicle, Politico, The Week (UK), and SinoVision News. He has also appeared in many state, province, and local media outlets around the United States and Canada.
Dr. Nathan serves as a cannabis consultant for government and industry. He is currently the Chief Medical Advisor for 4Front Ventures, a multistate medical cannabis company.
During his free time, Dr. Nathan publishes articles on a variety of historical subjects such as early written language, numismatics, animation, and the dawn of American football.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
